Pluripotent stem cells have distinct metabolic requirements, and reprogramming cells to pluripotency requires a shift from oxidative to glycolytic metabolism. Here, we show that this shift occurs early during reprogramming of human cells and requires hypoxia-inducible factors (HIFs) in a stagespecific manner. HIF1a and HIF2a are both necessary to initiate this metabolic switch and for the acquisition of pluripotency, and the stabilization of either protein during early phases of reprogramming is sufficient to induce the switch to glycolytic metabolism. In contrast, stabilization of HIF2a during later stages represses reprogramming, partly because of the upregulation of TNF-related apoptosis-inducing ligand (TRAIL). TRAIL inhibits induced pluripotent stem cell (iPSC) generation by repressing apoptotic caspase 3 activity specifically in cells undergoing reprogramming but not human embryonic stem cells (hESCs), and inhibiting TRAIL activity enhances human iPSC generation. These results shed light on the mechanisms underlying the metabolic shifts associated with the acquisition of a pluripotent identity during reprogramming.
INTRODUCTION
In contrast to differentiated cells, human embryonic stem cells (hESCs) rely mainly on glycolysis for their source of energy, regardless of oxygen availability (Folmes et al., 2011; Panopoulos et al., 2012; Varum et al., 2011; Zhang et al., 2011; Zhou et al., 2012) . Pluripotent cells share this metabolic particularity with cancer cells (Warburg effect) (Cairns et al., 2011) . In both cell types, glycolytic genes are upregulated, mitochondrial activity is reduced, and lactate production is significantly increased (Panopoulos et al., 2012; Varum et al., 2011; Yanes et al., 2010) . Furthermore, it has recently been proposed that the metabolic properties of stem cells and cancer cells are important for their identity (Greer et al., 2012; Rafalski et al., 2012) . However, it is not yet clear how stem cells gain this metabolic signature and how they again activate mitochondrial oxidative phosphorylation pathways during differentiation.
The bioenergetics of pluripotent cells can vary depending on their developmental stage. For example, mouse epiblasts stem cells, which are believed to be at the same primed stage as hESCs, are also highly glycolytic, whereas more naive mouse ESCs are bivalent in their energy production, switching from glycolysis to mitochondrial respiration on demand (Zhou et al., 2012) . Human induced pluripotent stem cells (iPSCs) are usually reprogrammed from somatic cells to a primed stage and are very metabolically similar to hESCs (Panopoulos et al., 2012; Suhr et al., 2010; Varum et al., 2011) . Therefore, a metabolic switch from oxidative to highly glycolytic needs to take place during iPSC formation. Supporting this idea, the inhibition of glycolysis reduces reprogramming efficiency, whereas stimulation of glycolytic activity enhances iPSC generation (Folmes et al., 2011; Panopoulos et al., 2012; Zhu et al., 2010) . How iPSCs establish a Warburg-like metabolic phenotype during the reprogramming process is largely unknown.
The dependency of stem cells on glycolysis to produce ATP could be an adaptation to low-oxygen tensions in vivo, given that hypoxia has appeared as a key feature of the stem cell niche (Mohyeldin et al., 2010; Suda et al., 2011) . Furthermore, low oxygen levels are beneficial for embryonic stem cells (hESCs), adult stem cells (Danet et al., 2003; Ezashi et al., 2005; Morrison et al., 2000; Simsek et al., 2010; Studer et al., 2000) , and cancer cells (Axelson et al., 2005; Cabarcas et al., 2011; Mathieu et al., 2011; Takubo and Suda, 2012) . Cellular adaptation to hypoxic conditions is mainly mediated through the activation of the oxygen-sensitive transcription factors, hypoxia-inducible factors (HIFs). In normoxia, HIF1a and HIF2a undergo prolyl hydroxylation, which leads to specific binding to the ubiquitin E3 ligase Von Hippel-Lindau, polyubiquitination, and proteasomal degradation. However, HIF1a and HIF2a are stabilized in low oxygen levels, dimerize with HIF1b, and control the transcription of multiple target genes, including genes involved in glucose metabolism (Pouyssé gur et al., 2006; Semenza, 2003) . HIF1a is expressed ubiquitously, whereas HIF2a expression is more tissue restricted, and both factors have essential roles during development (Compernolle et al., 2002; Iyer et al., 1998; Ryan et al., 1998) . Increasing evidence suggests that HIFs can activate factors involved in pluripotency and regulate the stem cell phenotype in both normal and cancer cells (Ezashi et al., 2005 , Takubo and Suda, 2012 , Covello et al., 2006 Mathieu et al., 2011 Mathieu et al., , 2013 . In addition, hypoxia enhances the generation of iPSCs (Yoshida et al., 2009) . However the mode of function of HIFs in the process is not fully understood. Given that HIF2a has been shown to activate Oct4 and that HIF2a-deficient embryos have severely reduced numbers of primordial germ cells (Covello et al., 2006) , it is believed to be the HIF family member that regulates stem cells (Das et al., 2012; Franovic et al., 2009; Heddleston et al., 2009; Li et al., 2009; Mohyeldin et al., 2010) . However, recent data indicate that HIF1a can also regulate stem cell properties (Takubo et al., 2010; Wang et al., 2011) . Therefore, it is important to dissect whether HIF1a and HIF2a are involved in the acquisition of stem cell fate and, in particular, in the mechanism underlying the hypoxia effect in reprogramming and whether HIFs are responsible for the metabolic shift during reprogramming.
We now show that both HIF2a and HIF1a are essential for the metabolic changes required early for iPSC generation in humans. Furthermore, we show that HIF2a is required at early stages, but is detrimental at later stages, of reprogramming. HIF1a and HIF2a are sufficient to induce the stem-cell-specific metabolic switch. However, prolonged HIF2a stabilization represses reprogramming because of the upregulation of TNFrelated apoptosis-inducing ligand (TRAIL). These data reveal a similarity between normal reprogramming and cancer progression; both require early metabolic switch induced by HIF1a and HIF2a, and both are sensitive to the presence of TRAIL.
RESULTS

A Metabolic Switch Occurs Early during the Reprogramming Process
The metabolism of primed PSCs differs from the one observed in naive PSCs or many differentiated cells (Varum et al., 2011; Zhou et al., 2012) . Primed stem cells show reduced mitochondrial activity and rely on glycolysis, whereas differentiated cells produce the majority of their ATP by mitochondrial oxidative phosphorylation. We used the reprogramming assay (Park et al., 2008; Takahashi et al., 2007; Yu et al., 2007) to analyze the requirements for the acquisition of the metabolic state of primed PSCs. Human fibroblasts were reprogrammed into an iPSC state with the four reprogramming factors Oct4, Sox2, Lin28, and Nanog (OSLN). To characterize the metabolic profiles of the cells, we measured a metabolic parameter that mainly defines the mitochondrial respiration levels, oxygen consumption rate (OCR) under various conditions and treatments with Seahorse Extracellular Flux Analyzer (Zhou et al., 2012) . We treated the cells with mitochondrial ATP synthase inhibitor, oligomycin, and then a proton gradient discharger, carbonyl cyanide 4-(trifluoromethoxy)phenylhydrazone (FCCP), in order to measure the maximal turnover of the electron transport chain uncoupled from ATP synthesis. This analysis revealed the maximal mitochondrial reserve in the presence of glucose (Goldsby and Heytler, 1963; Heytler, 1963) . Fibroblasts showed significantly higher levels of maximal respiratory capacity than hESCs and iPSCs ( Figure 1A ; Figure S1A available online). These results, in line with previous findings (Folmes et al., 2011; Hansson et al., 2012) , suggest that a switch from oxidative to glycolytic metabolism occurs during the iPSC reprogramming process. Furthermore, we examined the kinetics of the metabolic switch by analyzing the OCR and extracellular acidification rate of the cells at different time points of the reprogramming process and found that the FCCP response after oligomycin treatment was already significantly reduced at day 8 (D8) in reprogramming fibroblasts in comparison to control fibroblasts ( Figures 1B, 1C , and S1B-S1D). These data indicate that the metabolic changes initiate early in the reprogramming process and support the previous gene expression and proteomics analysis in mouse and human reprogramming (Folmes et al., 2011; Hansson et al., 2012) .
Reprogramming Process Has Hypoxic Expression Signature
To reveal the key metabolic genes involved in the transition, we analyzed the gene expression profiles of reprogramming cells and observed an increased expression of metabolic genes in early (D12) and late (D30) time points of the entire fibroblast population exposed to reprogramming factors ( Figures 1D, S1E , and S1F and Table S1 ). The majority of the increased metabolic genes during early reprogramming are hypoxia-responsive genes ( Figure 1E ). We validated the early upregulation in reprogramming process for ALDOC, ENO3, and PKM2 by quantitative PCR (qPCR; Figure 1F ). Given that the reprogramming experiments were performed in normoxia, we tested whether performing the process in hypoxic conditions would be beneficial ( Figure 2A) . Indeed, the reprogramming process is significantly more efficient when performed in hypoxic conditions. In comparison to 20% O 2 , both 2% and 5% O 2 promote iPSC colony formation in various cell lines, including IMR90, MRC5, and JM1 (Figures 2A, 2B , and S2A-S2C), confirming that hypoxia is beneficial for iPSC induction (Yoshida et al., 2009) . Using western blot analysis, we showed that the two main hypoxia-responsive factors, HIF1a and HIF2a, were stabilized in hypoxic reprogramming process ( Figures 2C, S2D , and S2E).
To test whether HIF1a and HIF2a are stabilized in the normoxic (20% O 2 ) reprogramming process, we analyzed multiple time points in normal reprogramming ( Figures 2D and S2F ). Both HIF1a and HIF2a proteins were stabilized during normoxic reprogramming ( Figures 2C, 2D , and S2F). To test whether HIFs are also transcriptionally active during the reprogramming in normoxic oxygen environment, we introduced an HIF reporter that contains six HIF-minimal binding sites in front of enhanced yellow fluorescent protein (eYFP) into the fibroblasts used for reprogramming assay (HFF1). This sensor has shown to react to hypoxia and both HIF1a and HIF2a activity (Figure S2G ). By D7 of reprogramming, the fluorescent signal had increased significantly, suggesting that HIF1a and/or HIF2a are activated during the reprogramming process ( Figure 2E ). However, when iPSC colonies were formed, the signal was highly reduced, suggesting that the viral construct (Table S1 ) expression patterns display dynamic changes in early (D12) and late (D30, p = 0.001) reprogramming cells in comparison to IMR90 fibroblasts. In comparison to IMR90 fibroblasts, 74 metabolic genes show higher expression level in iPSCs and hESCs. Among those 74 genes, 27 are upregulated in early (D12) reprogramming cells, whereas an additional 22 genes (total of 49) are upregulated in late (D30) reprogramming cells. Arrows indicate the proportion of the 74 upregulated genes in each category. (E) Microarray expression data are shown for metabolic genes that are upregulated more than 2-fold in early (OSLN D12) and late (OSLN D30) IMR90 reprogramming cells in comparison to the IMR90 fibroblasts. Hypoxia-responsive genes are highlighted in red. (F) qRT-PCR validates the upregulation of some of these hypoxia-responsive genes in early reprogramming fibroblasts in comparison to control IMR90 fibroblasts. p values were calculated with a Student's t test. *p < 0.05; **p < 0.01; ***p < 0.001. Scale bars show SEM for at least three separate experiments. See also Figure S1 . was inactivated in the stem cell stage, as has been observed previously (Takahashi et al., 2007; Xia et al., 2007; Yu et al., 2007) .
HIF2a Is Required for the Metabolic Switch during Early Reprogramming
To test whether HIF1a and/or HIF2a are required for the metabolic switch observed during reprogramming, we used HIF1a and HIF2a small hairpin RNA (shRNA) constructs that resulted in a significant reduction of HIF1a and HIF2a protein levels, respectively (Figures 2F, 2G , S3A, and S3B). Importantly, when either HIF1a or HIF2a were significantly reduced starting from the initiation of the reprogramming process, at the D8-D10 time point, the total OCR increase after FCCP addition was abnormal. Although HIF1a shRNA effect in the metabolic switch was not statistically significant, HIF2a knockdown (KD) significantly blocked the process (Figures 2H-2K and S3C). At D8, the reprogramming cells with HIF2a KD showed a high OCR increase after FCCP treatment that was comparable to fibroblasts. This starkly contrasts the highly reduced OCR detected in the control reprogramming samples . Furthermore, at the end of the reprogramming process, the number of iPSC colonies was also significantly reduced when HIF2a was knocked down during the process in both normoxia and hypoxia ( Figures 2L and S3D ). The iPSC colony formation was also highly reduced when HIF1a was knocked down during the process ( Figure 2M ). The reduction observed in iPSC induction when HIF1a or HIF2a were knocked down was not due to significantly reduced proliferation rates ( Figure S3E ). Furthermore, we showed a reduction in the key metabolic hypoxia-responsive genes in the reprogramming cells in which HIF1a or HIF2a was knocked down ( Figures 2N and S3F ). Later in the reprogramming process, an increase of small iPSC-like colonies was observed in some of the HIF1a KD plates ( Figures S3G-S3J ). Altogether, these data suggest that both HIF2a and HIF1a are required for the metabolic switch that initiates early during the reprogramming process and that this step is necessary for iPSC colony formation.
Reprogramming Process Requires Controlled HIF2a Activity
Because hypoxia is beneficial for reprogramming and HIF2a and HIF1a are required for the process, we tested whether constitutive stabilization of HIF1a and/or HIF2a would enhance iPSC generation by overexpressing nondegradable forms of HIF1a and HIF2a during reprogramming (Pro 402, 564 /Ala mutations and Pro 405, 531 /Ala mutations, respectively; Figures 3A and S4A) . HIF1a overexpression (OE) during reprogramming significantly increased the efficiency of iPSC colony formation in normoxia as well as in hypoxia in IMR90 and MRC5 fibroblast cell lines ( Figures 3B-3D ). However, surprisingly prolonged stabilization of HIF2a significantly repressed the reprogramming process in these conditions ( Figures 3B-3D ), even in combination with HIF1a ( Figures 3B and 3C ). To confirm that the morphologically and alkaline phosphatase (AP)-staining-identified colonies consist of true pluripotent cells, we stained all cells late in reprogramming process with TRA-1-60 and quantified the positive cells by FACS analysis (Figures 3E-3G and S4B-S4F). Importantly, similar to the morphological analysis, TRA-1-60-positive cell number was increased when HIF1a was stabilized but significantly reduced with HIF2a stabilization (Figures 3F and 3G) . As expected, TRA-1-60 FACS analysis also validated the loss-of-function data (Figures 3F, 3G, and 2M) .
This difference in HIF1a OE and HIF2a OE effect on reprogramming was not caused by differences in cell proliferation rates ( Figure S3E ). The iPSC colonies derived from HIF1a-expressing or control samples displayed hESC-like morphology, selfrenewal capacity, AP activity, and endogenous NANOG and OCT4 mRNA expression ( Figures 3H, 3I , and S4G). In addition, their metabolic profile resembled the hESC metabolic profile, as evident in the diminished mitochondrial functional reserves induced by FCCP following oligomycin treatment ( Figure 3J ). Cells in these iPSC colonies were pluripotent, given that they had the capacity to differentiate into all three germ layers, as indicated by upregulation of mesoderm, endoderm, and ectoderm markers in embryoid body (EB) assays ( Figure 3K ) (Yu et al., 2007) . Despite several attempts, we were not able to maintain the few colonies derived from the HIF2a-overexpressing cells. Altogether, these data show that, although continuous and prolonged OE of HIF1a is beneficial for reprogramming process, prolonged HIF2a activation represses iPSC formation.
HIF2a Function at Different Stages of Reprogramming
We showed that a loss of HIF2a is detrimental for reprogramming ( Figures 2L and S3D) . Surprisingly, although continuous HIF1a activation is beneficial, continuous activation of HIF2a represses iPSC induction, suggesting that the reprogramming process requires tightly controlled HIF2a activity. To understand the timing of HIF2a function in the process, instead of reducing HIF2a levels from the beginning of reprogramming, we infected the cells with shRNA against HIF2a in the middle of the reprogramming process (D12) and measured the total number of iPSC colonies formed late in the reprogramming process (D33; Figures 3L  and 3M ). Interestingly, although HIF2a shRNA reduced iPSC colony number significantly when introduced early (D0; Figure 2L ), no obvious defect was observed when HIF2a was knocked down in the middle (D12) of the reprogramming process ( Figures  3L and 3M) . However, when the nondegradable form of HIF2a was overexpressed in the middle of the reprogramming process, the iPSC colony number was significantly reduced (Figures 3L and 3M) . These data suggest that HIF2a is required early, but not late, in iPSC induction. Furthermore, HIF2a needs to be downregulated at the latter part of the reprogramming process, given that constitutive activation of HIF2a late in the process causes a significant repression of reprogramming.
HIF1a and HIF2a Overexpression Is Sufficient to Induce Metabolic Changes
To analyze the mechanism of HIF1a and HIF2a action in somatic cells, we expressed constitutively active HIF1a and HIF2a in fibroblasts without the reprogramming factors. First, we validated the HIF1a and HIF2a activity by showing that in MRC5 fibroblast HIF1a and/or HIF2a OE results in the upregulation of HIF target genes carbonic anhydrase 9 and miR-210 ( Figures  4A and 4B ). To test whether overactivation of HIF1a or HIF2a could affect the metabolism of fibroblasts without the addition of the reprogramming factors, we analyzed the maximum OCR change after FCCP addition in these conditions. Importantly, (legend continued on next page) OE of HIF1a or HIF2a reduced the oxidative metabolism, and this metabolic change was more prominent when both transcription factors were activated simultaneously ( Figure 4C ). Furthermore, we showed that the observed reduction on mitochondrial activity was not due to the reduction of mitochondrial number by utilizing mitochondrial DNA copy-number assay ( Figure 4D ). Because no significant change in mitochondrial copy number was found in HIF1a and HIF2a OE cells ( Figure 4D ), mitochondrial activity regulated by gene expression, rather than mitochondrial number, is critical for the metabolic switch observed in fibroblasts.
Similarly, OCR reduction was accelerated when HIF1a or HIF2a were overexpressed with OSLN during the reprogramming assay ( Figure 4E ). Therefore, we tested whether HIF1a and/or HIF2a OE would accelerate the increase in expression patterns of metabolic genes observed during reprogramming ( Figure 1D ). In order to examine the change in gene expression that occurs at various stages of the reprogramming process when HIF2a is OE during OSLN-induced reprogramming, we performed a microarray analysis ( Figure S5A ). First, we validated the microarray data by showing that stem cell markers were highly enriched in reprogramming cells and that hypoxia target genes were upregulated in HIF2a OE reprogramming cells ( Figures S5B and S5C ). Our microarray analysis revealed that hypoxia target genes were enriched in HIF2a OE samples in comparison to fibroblasts ( Figures S5D and S5E) . Furthermore, HIF2a OE and HIF1a OE accelerated the metabolic gene expression during the reprogramming process ( Figure S5F ). qPCR validation revealed that many of the metabolic genes normally upregulated late in reprogramming process were already upregulated at the D12 time point because of HIF2a and HIF1a overexpression ( Figure 4F ), suggesting hastened kinetics of the metabolic switch in the reprogramming cells.
Among the metabolic genes upregulated late (D30) during normal reprogramming that were expressed earlier (D12) in HIF1a and HIF2a OE cells was pyruvate dehydrogenase kinase 3 (PDK3; Figures 4F and S5F-S5H) . PDK3, an enzyme that blocks the conversion of pyruvate to acetyl-CoA, is significantly enriched in hESCs and hypoxic tumor cells (Mathieu et al., 2011; Stadler et al., 2010) . Unlike other PDKs, PDK3 is not inhibited by excess pyruvate and therefore is considered a key regulator for a switch from oxidative to glycolytic metabolism. We studied the kinetics of PDK3 upregulation when HIF1a and/or HIF2a are overexpressed during reprogramming by qRT-PCR. Although, in control, an 8-fold increase in PDK3 expression was observed at D30 of the reprogramming process, HIF1a and HIF2a accelerated this process, given that upregulation of PDK3 was observed at D7 or D12 in reprogrammed MRC5 or IMR90 cells ( Figures 4F,  4G, and S5H ). Furthermore, we tested whether the inhibition of PDK3 could suppress the HIF1a-induced increase in iPSC formation. Using the chemical inhibitor Radicicol (Kato et al., 2007) , we showed that reduction of PDK3 activity reduced the number of iPSC colonies in HIF1a-overexpressing reprogramming cells as well as normal reprogramming cells ( Figures 4H  and S5I ), suggesting an important functional role for PDK3 in HIF1a-induced increase in iPSC induction. However, given that Radicicol did not fully eliminate iPSC induction, additional HIF targets are probably involved in the process.
These data show that HIF1a and HIF2a together are sufficient to induce the metabolic switch in fibroblasts. Similarly, HIF1a and HIF2a stabilization in hypoxic cells is shown to be invariably sequential (Keith et al., 2012; Zhou et al., 2011) . These data support the hypothesis that HIF1a and HIF2a have a combinatorial, perhaps sequential, role in the metabolic switch observed in early iPSC induction. However, although HIF1a stabilization is beneficial for the process, HIF2a stabilization late in the process is surprisingly detrimental for iPSC induction.
HIF2a Inhibits Reprogramming through TRAIL
In accordance with the observation that HIF2a is required early, but not late, in reprogramming, we also observed that both MRC5 and IMR90 fibroblasts with HIF2a OE give rise to approximately equal or larger number of precolonies in early time points in comparison to the controls (before D14; Figures 5A, S6A , and S6B), suggesting that HIF2a overexpression is beneficial during the early phase of reprogramming. However, a significant repression in colony formation and PDK3 expression was observed in HIF2a overexpressing samples at later time points ( Figures 4G, 4H , 5A, and S6A). Similarly, HIF2a OE initiated in the middle of reprogramming process (D12) dramatically reduced iPSC colony formation ( Figure 3M ), suggesting that HIF2a OE late during reprogramming is detrimental for iPSC formation. Therefore, we examined the gene expression profiles of HIF2a-overexpressing and control cells at D30 of the reprogramming process in order to identify the key HIF2a target that can repress iPSC formation.
As expected, the expression of stem cell markers was only enriched in the control samples, not HIF2a OE cells, validating the lack of iPSC colonies ( Figures 5B, 5C , S6C, and S6D). Importantly, we identified TRAIL as the most upregulated gene with stabilized HIF2a at late stage of reprogramming in comparison to controls (Figures 5D and S6E ). This upregulation of TRAIL was not observed early in reprogramming ( Figure S6F ) and was specific for HIF2a OE, given that no effect in TRAIL expression was observed with stabilized HIF1a (Figure 5E ). Furthermore, the significant upregulation of TRAIL was also observed when HIF2a OE was induced late in reprogramming (D12; Figure 5F ) and a trend of TRAIL downregulation was observed in HIF2 KD late reprogramming samples ( Figure S6G ).
To analyze whether TRAIL expression was sufficient to reproduce the repressive function of HIF2a, we administered TRAIL recombinant protein into the cell-culture media during reprogramming process. Importantly, when 50 or 100 ng/ml of TRAIL was administered to the reprogramming process, fibroblasts continued dividing, but no iPSC colonies were produced ( Figures 5G and S6H-S6J See also Figure S4 .
and S6K-S6L). These data show that HIF2a exerts its dominant repression at the late stage of reprogramming through TRAIL.
TRAIL Effect in Reprogramming
To test whether TRAIL is normally expressed and has a repressive effect during normal reprogramming, we added TRAIL Ab during normal reprogramming (from D7 on) and counted the iPSC colony number at D17 and D21 in the process. Importantly, the colony number was significantly increased when endogenous TRAIL was sequestered by TRAIL Ab ( Figure 5I ). The colonies formed were able to undergo self-renewing division and expressed endogenous Oct4 ( Figure S6L ). These data show that normal reprogramming generates low levels of endogenous TRAIL, which has a repressive property on the reprogramming process, and hence we proceeded to reveal the mechanism of TRAIL action in the process. TRAIL, by activating a specific set of receptors, can either induce apoptosis through the caspase pathway or display an antiapoptotic effect, mostly through nuclear factor kB (NF-kB) signaling (Mé rino et al., 2007; Walczak et al., 1999) . We tested whether HIF2a OE activates the caspase pathway through TRAIL in the reprogramming cells by analyzing the level of cleaved PARP, the cleavage target of active caspase 3. Instead of caspase activation, we observed the repression of caspase, as indicated by the significant reduction of cleaved PARP in HIF2a, but not HIF1a-overexpressing, reprogramming cells ( Figures 5J-5L ). Furthermore, we tested whether exogenously added TRAIL protein in the reprogramming system can affect PARP cleavage and found that, 8 hr after TRAIL addition at D17 of iPSC reprogramming, a reduction of PARP was also detected ( Figure 5M ).
Given that reprogramming cells require active caspases (Li et al., 2010) , a reduction of caspase activity could be causal for the lack of iPSC formation in cells constitutively overexpressing HIF2a. Gene expression profiling data further revealed that expression of NF-kB targets, and in particular cFLIP and XIAP, inhibitors of caspase activation, are higher in HIF2a-overexpressing cells than the control (Figures 5N, 5O , and S6M and Table S2 ), suggesting that TRAIL could induce antiapoptotic activity instead of apoptotic signaling in reprogramming cells. Importantly, TRAIL Ab significantly reduced the upregulation of XIAP observed in HIF2a-overexpressing reprogramming cells ( Figure 5O ).
hESCs Are Not Responsive to TRAIL Because reprogramming cells are sensitive to TRAIL, we tested TRAIL effect on pluripotent hESCs and iPSCs and found that, surprisingly, these pluripotent cells can self-renew in the presence of TRAIL ( Figures 6A, 6B , and S7A-S7D). Furthermore, we found that this difference in TRAIL responsiveness correlated with differential expression of TRAIL receptors. Although DR4 expression is 10-fold lower in reprogramming cells in comparison to hESCs, decoy receptor 2 (DcR2) expression is significantly higher in fibroblasts (IMR90, 8% of actin; Figure S7E ) and reprogramming cells (1.3% of actin) than in hESCs or iPSCs (0.05% of actin; Figures 6C and S7D) . Previous data have shown that DcR2, upon binding to TRAIL, can induce NF-kB signaling, which imposes an inhibitory effect on caspase activation (Ehrhardt et al., 2003; Kim et al., 2002) . A lower level of DcR2 in hESCs might protect these cells from TRAIL-induced anticaspase signals. Accordingly, in pluripotent cells cultured in the presence of TRAIL for prolonged periods, we found that PARP cleavage is not reduced in comparison to the controls ( Figures  6D and S7A-S7C ). These results show that TRAIL does not inhibit caspase activity in hESCs or iPSCs.
DISCUSSION
This study shows that reprogramming has distinct stages. Although both HIF1a and HIF2a are required, HIF2a has a stage-specific function in the process. HIF2a is essential in early, but not late, in reprogramming. When stabilized, HIF2a is beneficial in early reprogramming, but prolonged stabilization of HIF2a, in contrast to HIF1a dramatically blocks iPSC formation. We identified the mechanism for prolonged HIF2a repressive action in reprogramming. Through TRAIL, HIF2a inhibits caspase 3 activity, thereby repressing iPSC formation. Unlike reprogramming cells, hESCs can self-renew in the presence of TRAIL in culture. This correlates with the low expression of DcR2 in hESCs.
Human embryonic stem cells are glycolytic (Panopoulos et al., 2012; Varum et al., 2011; Zhou et al., 2012) , and the reprogramming process undergoes and requires a metabolic switch from oxidative to glycolytic (Armstrong et al., 2010; Panopoulos et al., 2011 Panopoulos et al., , 2012 Prigione et al., , 2014 Varum et al., 2011) . This metabolic switch precedes the stem cell fate marker expression (Folmes et al., 2011; Zhou et al., 2012) . Here, we show, by analyzing the metabolic flux, that the metabolic switch begins early in the reprogramming process. These data are in accordance with recent expression analysis of mouse reprogramming cells and human reprogramming with cMyc as one of the reprogramming factors Prigione et al., 2014) . Interestingly, both HIF1a and HIF2a enhance and are required for this switch, possibly through separate transcriptional targets (Keith et al., 2012; Loboda et al., 2010) . An interesting question is whether the metabolic switch alone is sufficient to initiate the reprogramming process. We showed that prolonged stabilization of HIF1a and HIF2a in fibroblasts is sufficient to induce the metabolic switch from oxidative to highly glycolytic observed in stem cells; however, it was not sufficient to induce pluripotency. This could be due to the repressive effect of HIF2a in iPSC induction through TRAIL. It will be important for future research to test whether switching cell metabolism with more tightly controlled HIFa expression, alone and/or in combination with other factors, could be another avenue for driving somatic reprogramming.
Our findings show that HIF2a is required during the early iPSC reprogramming process to promote the metabolic switch. However, prolonged stabilization of HIF2a represses iPSC formation through TRAIL-induced inhibition of caspase 3 signaling. Previously, it was shown that the activation of apoptotic caspases occurs during the reprogramming process, and their inhibition prevents iPSC generation (Li et al., 2010) . Now, we show that HIF2a OE inhibits the caspase 3 activity induced by the reprogramming factors. We also show that HIF2a inhibits iPSC formation through TRAIL. The binding of TRAIL to its cognate receptors DR4 and DR5 activates both apoptotic and nonapoptotic signaling, whereas binding to its decoy receptor 2 (DcR2) only activates antiapoptotic pathways (Degli-Esposti et al., 1997; Sanlioglu et al., 2005) . Interestingly, reprogramming cells have a low level of DR4 but a high level of DcR2. In these cells, TRAIL could activate DcR2, and thereby the NF-kB pathway that can repress caspase activity (Ehrhardt et al., 2003; Kim et al., 2002) . Furthermore, given that reprogramming cells require an active caspase pathway (Li et al., 2010) , TRAILdependent caspase inhibition could block iPSC formation (Figure 6E) . Our finding that NF-kB targets, and in particular, the antiapoptotic gene XIAP, are upregulated in HIF2a OE reprogramming cells in comparison to controls ( Figures 5N and 5O ) support this hypothesis. Alternatively, DcR2 could form a heteromeric complex with DR5 and inhibit caspase activation through steric hindrance (Mé rino et al., 2006) (Figure 6E ). We showed that both fibroblasts and reprogramming cells have higher expression of DcR2 than hESCs, which may be due to low p53 expression in hESCs (Liu et al., 2005) . Fibroblasts survive with TRAIL-induced inhibition of the caspase pathway, whereas fibroblasts in the process of becoming iPSCs are sensitive to TRAIL, indicating that similar DcR2 levels in two cell types can lead to different outcomes because of cell-dependent responses to the downstream pathway.
This study presents an example of a significant difference between HIF1a and HIF2a function in the same cellular process. Our results suggest that HIF1a and HIF2a may play nonoverlapping roles in iPSC reprogramming process: HIF1a and HIF2a are essential for the metabolic switch and induction of pluripotency. Additionally, prolonged stabilization of HIF1a increases iPSC induction; however, surprisingly prolonged stabilization of HIF2a significantly represses reprogramming through TRAIL activation (Figure 7) . A fine balance exists between the differential roles of the two HIFa factors in early embryonic development, a period when physiological hypoxia is critical for the formation and early differentiation of both germline and somatic stem cells (Dunwoodie, 2009 ). Our findings in this study provide further evidence on functional difference between HIF1a and HIF2a (Hu et al., 2007; Husa et al., 2010) . Reprogramming assays can be used in the future to reveal how structural differences between the two HIFa factors lead to their diverse functional outcomes.
Along with previous studies, this study shows that TRAIL does not induce death in hESCs, cancer stem cells or adult stem cells (Kruyt and Schuringa, 2010) . However, TRAIL is detrimental for cancer cells (Mé rino et al., 2007; Walczak et al., 1999) . Our study now reveals that TRAIL also represses the iPSC reprogramming process. These data suggest a similar mechanism in response to TRAIL in cancer cells and reprogramming cells. In general, the results suggest that cells undergoing reprogramming process may have similar characteristics to the cells undergoing progression toward aggressive tumor cell, allowing us to propose that cancer progression is a slow reprogramming process. First, cancer cells and cells under reprogramming (iPSC induction) both change their metabolism from oxidative to highly glycolytic early during the process. Second, HIFs regulate the switch in both cell types. Third, cancer cells and reprogramming cells are sensitive to TRAIL, whereas cancer stem cells and PSCs are resistant to TRAIL. These similarities between cancer cells and reprogramming cells may allow us to utilize somatic cell reprogramming process in the future as a model for understanding mechanisms and events involved in the cancer progression and to learn from our current knowledge in cancer progression in order to facilitate understanding of the acquisition of pluripotency.
EXPERIMENTAL PROCEDURES
Cell Culture and Reprogramming hESCs and isolated iPSCs were maintained as previously described (Ware et al., 2006) . Reprogramming of human fibroblasts (MRC5, IMR90, and HFF1) was carried out with OSLN lentiviruses (generated from Addgene constructs #21162 and #21163) (Yu et al., 2009) . In order to examine hypoxia effect on iPSC formation, cells were cultured under 2% or 5% of O 2 from D7 postinfection. The number of iPSC colonies was defined as the number of AP-, Oct4-GFP-, and/or Tra-1-60-positive colonies. See details in the Supplemental Experimental Procedures.
Overexpression and Inhibition of HIF1a or HIF2a during Reprogramming Retroviruses expressing nondegradable HIF1a or HIF2a (Addgene constructs #19005 and #19006) were infected along with OSLN on D0. An empty vector (EV) construct was used as a control. In order to examine the role of HIF2a in the later stage of the reprogramming process, OSLN When oxidative fibroblasts are reprogrammed into glycolytic pluripotent cells, metabolic switch from oxidative to glycolytic occurs. Our study shows that such a metabolic switch takes place in early stage of the reprogramming process, and HIF1a and HIF2a are essential for this metabolic change. In contrast, constitutive HIF2a stabilization is detrimental for the reprogramming process at the later stage, given that it promotes TRAIL expression, which prevents reprogramming.
reprogramming cells were infected with HIF2a retrovirus at D12. HIF1a and HIF2a KD were obtained with shRNA constructs (shHIF1a in comparison to shRNA scramble control; Addgene plasmids #22131/shHIF2#2 and #22132/shHIF2#3) (Nemetski and Gardner, 2007; Li et al., 2007) . HIF1a and HIF2a OE and KD were validated by western blot analysis.
iPSC Formation with Recombinant TRAIL, TRAIL Ab, or PDK3 Inhibitor Administration During the iPSC reprogramming process, human TRAIL recombinant protein (R&D Systems; 50 or 100 ng/ml), human TRAIL polyclonal antibody (R&D Systems; 75 or 50 ng/ml), or PDK3 inhibitor Radicicol (Sigma-Aldrich, 36.5 ng/ml) (Kato et al., 2007) were added to OSLN-infected fibroblasts on D7 and every other day along with media change.
Western Blot Analysis, qRT-PCR Analysis, and Mitochondrial DNA Copy-Number Measurement Standard protocols were used. See details in the Supplemental Experimental Procedures. Primers used in our study are listed in Table S3 .
Whole-Genome-Wide Microarray Analysis Total RNA isolated from IMR90 and MRC5 reprogramming cells infected with HIF2a OE virus or EV control at days 12 and 30 were used in the microarray analysis. RNA qualification, Agilent microarray labeling, hybridization, and scanning were performed in microarray facility at the Institute for Systems Biology. Any intensity-dependent biases were removed in the data with the normalize.qspline function in the affy Bioconductor package.
OCR Measurement with Seahorse Cellular Flux Assays
Mito Stress and Glucose Stress assays were performed on fibroblasts and reprogramming fibroblasts (infected by OSLN) with the Seahorse XF96 Extracellular Flux Analyzer. The OCR values were further normalized to the number of cells and quantified by the Hoechst staining (HO33342; Sigma-Aldrich). See the Supplemental Experimental Procedures for details.
In Vivo Detection of HIF Activity with eYFP Reporting System In order to test the level of HIF transcriptional activity during reprogramming, fibroblasts were infected with HIF reporter HBR-6U lentivirus before undergoing normal reprogramming assay in normoxia.
Statistical Analysis
Throughout the paper, p values were calculated with Student's t tests. *p < 0.05, **p < 0.01, ***p < 0.001. Scale bars show the SEM of at least three separate experiments.
ACCESSION NUMBER
Microarray data have been deposited to the NCBI Gene Expression Omnibus under accession number GSE54898.
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